Bristol-Myers Squibb buy fenjal
Start price
03.01.23
/
50%
€68.08
Target price
03.01.24
-
Performance (%)
-32.29%
End price
28.12.23
€46.10
Summary
This prediction ended on 28.12.23 with a price of €46.10. Massive losses of -32.29% were the result for the BUY prediction by fenjal. Dividends of €2.13 are taken into consideration when calculating the performance. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bristol-Myers Squibb | 4.797% | 4.797% | -8.935% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% |
According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons
Comments by fenjal for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy Bristol-Myers Squibb
In the thread Trading Bristol-Myers Squibb
Buy beendet
Stopped prediction by fenjal for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.10
01.05.24
01.05.24
-
01.05.25
01.05.25
11.46%
26.07.24
26.07.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€66.35
25.03.22
25.03.22
-
25.04.22
25.04.22
6.07%
26.04.22
26.04.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.54
18.04.19
18.04.19
€52.32
09.06.20
09.06.20
30.00%
09.06.20
09.06.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating